...
首页> 外文期刊>BJU international >Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study.
【24h】

Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study.

机译:针刺活检的格里森评分与前列腺癌根治术标本的一致性:一项基于人群的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To study the concordance between the Gleason scores of needle biopsies and radical prostatectomy (RP) specimens in a population-based registry, to clarify whether the concordance depends on the annual number of RP specimens assessed in the pathology unit, and to identify preoperative clinical factors that predict upgrading from a Gleason score of or=7 in the RP specimen. PATIENTS AND METHODS: Through the Cancer Registry of Norway, we identified 1116 patients with available Gleason scores from biopsy and RP specimens. Concordance was evaluated using the kappa coefficient, and predictors of concordance were assessed in univariate and multivariate logistic regression analyses. RESULTS: The Gleason scores were identical in biopsy and RP specimens in 591 of the 1116 (53%) patients. The biopsy-based Gleason score more often under-graded (38%) than over-graded (9%) the RP-based Gleason score. Pathology units that examined >40 RP specimens annually had a higher concordance between the Gleason score in the biopsy and RP specimen than did lower-volume units. The rate of upgrading from a Gleason score of or=7 in the RP specimen increased with increasing preoperative prostate-specific antigen serum levels, and with increasing intervals between biopsy and RP. CONCLUSIONS: The concordance in Gleason score between biopsy and RP was highest among the pathology departments that regularly evaluated RP specimens. Careful consideration of clinical factors and biopsy grading might improve the identification of patients considered as suitable for active surveillance.
机译:目的:研究基于人群的注册表中针刺活检的Gleason评分与根治性前列腺切除术(RP)标本之间的一致性,以阐明该一致性是否取决于在病理学部门评估的RP标本的年度数量,并确定术前预测从活检的Gleason评分升至≥6到RP样本增至≥7的临床因素。患者和方法:通过挪威癌症登记处,我们从活检和RP标本中鉴定出1116例具有可用Gleason评分的患者。使用kappa系数评估一致性,并在单变量和多元logistic回归分析中评估一致性的预测因子。结果:1116名患者中的591名(53%)患者的活检和RP标本的格里森评分相同。基于活检的格里森评分与基于RP的格里森评分相比,评分较低(38%)多于评分高(9%)。每年检查40多个RP标本的病理单位,其活检的Gleason评分与RP标本之间的一致性高于小剂量单位。随着术前前列腺特异性抗原血清水平的升高,以及活检和RP之间的间隔时间的增加,从活检中的Gleason评分从 7的比率增加。结论:在定期评估RP标本的病理部门中,活检与RP之间的Gleason评分一致性最高。仔细考虑临床因素和活检分级可能会改善对认为适合主动监测的患者的识别。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号